PACTAID App in Adults With Type 1 Diabetes to Help Manage Exercise

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT06730906
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • PACTAID App — DEVICE
    The PACTAID app will provide real time decision support during exercise for patients with type 1 diabetes.

Study Details

The purpose of this trial is to test and refine the PACTAID smart phone application in adults with type 1 diabetes mellitus to help manage exercise while on automated insulin delivery systems with the goal of improving glycemic control during and after exercise as well as improving multiple other cardiovascular risk factors.

Key Dates

Start date
Jan 10, 2025
Status verified
May 2026
Primary completion
Dec 28, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Intervention Group
    Participants will utilize the PACTAID app for 8 weeks.

Primary Outcome Measure

Mean CGM glucose (mg/dL) [ Time Frame: Baseline, 4 weeks, 8 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905-

Find similar trials in Rochester, MN

By condition
Type 1 diabetes
By specialty
Endocrinology
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies